Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00957320
Recruitment Status : Withdrawn (no patients enrolled, decided not to pursue study)
First Posted : August 12, 2009
Last Update Posted : December 3, 2013
Information provided by (Responsible Party):
Frank Keller, Emory University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2012
  Actual Study Completion Date : August 2012